Abacavir/Lamivudine Mylan Pharma 600 mg / 300 mg Norge - norsk - Statens legemiddelverk

abacavir/lamivudine mylan pharma 600 mg / 300 mg

mylan ab - abakavirsulfat / lamivudin - tablett, filmdrasjert - 600 mg / 300 mg

Amikacin Macure 250 mg/ ml Norge - norsk - Statens legemiddelverk

amikacin macure 250 mg/ ml

macure pharma aps - amikacinsulfat - injeksjonsvæske, oppløsning - 250 mg/ ml

Atazanavir Accord 300 mg Norge - norsk - Statens legemiddelverk

atazanavir accord 300 mg

accord healthcare b.v. - atazanavirsulfat - kapsel, hard - 300 mg

Atazanavir Accord 200 mg Norge - norsk - Statens legemiddelverk

atazanavir accord 200 mg

accord healthcare b.v. - atazanavirsulfat - kapsel, hard - 200 mg

Reyataz 300 mg Norge - norsk - Statens legemiddelverk

reyataz 300 mg

orifarm as - atazanavirsulfat - kapsel, hard - 300 mg

Arikayce liposomal Den europeiske union - norsk - EMA (European Medicines Agency)

arikayce liposomal

insmed netherlands b.v. - amikacin sulfate - luftveisinfeksjoner - antibakterielle midler for systemisk bruk, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.

Evotaz Den europeiske union - norsk - EMA (European Medicines Agency)

evotaz

bristol-myers squibb pharma eeig - cobicistat, atazanavir - hiv-infeksjoner - antivirale midler til systemisk bruk - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 og 5.

Irinokabi 20 mg/ ml Norge - norsk - Statens legemiddelverk

irinokabi 20 mg/ ml

fresenius kabi oncology plc - irinotekanhydrokloridtrihydrat - konsentrat til infusjonsvæske, oppløsning - 20 mg/ ml